Michael Walsh Selected Research

Heart Failure

4/2022	Association of anti-neutrophil cytoplasmic antibody-associated vasculitis and cardiovascular events: a population-based cohort study.
1/2021	Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
10/2016	The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysis.
9/2015	The Safety of Eplerenone in Hemodialysis Patients: A Noninferiority Randomized Controlled Trial.
1/2008	Predictors of mortality after hip fracture: a 10-year prospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Walsh Research Topics

Disease

19	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 04/2022 - 07/2009
17	Vasculitis (Vasculitides) 01/2019 - 03/2007
14	Neoplasms (Cancer) 11/2021 - 05/2002
13	Acute Kidney Injury (Acute Renal Failure) 05/2021 - 05/2011
11	Chronic Kidney Failure (Chronic Renal Failure) 02/2022 - 09/2007
11	Chronic Renal Insufficiency 01/2022 - 12/2013
10	Hemorrhage 07/2022 - 12/2013
8	Stroke (Strokes) 07/2022 - 04/2004
7	Infections 01/2022 - 06/2006
6	Kidney Diseases (Kidney Disease) 01/2021 - 09/2007
5	Heart Failure 04/2022 - 01/2008
5	Atrial Fibrillation 04/2022 - 04/2006
5	Glomerulonephritis 01/2022 - 04/2011
5	Hypotension (Low Blood Pressure) 05/2021 - 12/2014
5	Inflammation (Inflammations) 05/2020 - 01/2007
4	Myocardial Infarction 04/2022 - 04/2015
4	Renal Insufficiency (Renal Failure) 11/2021 - 02/2013
4	Lupus Nephritis 01/2014 - 09/2007
4	Anemia 12/2009 - 04/2005
3	COVID-19 01/2022 - 06/2021
3	Type 2 Diabetes Mellitus (MODY) 11/2021 - 01/2019
3	Critical Illness (Critically Ill) 05/2021 - 01/2012
3	Restless Legs Syndrome (Restless Legs) 01/2021 - 08/2019
3	Coronary Artery Disease (Coronary Atherosclerosis) 11/2019 - 07/2005
3	Albuminuria 01/2019 - 01/2018
3	Wounds and Injuries (Trauma) 01/2017 - 01/2007
3	Pain (Aches) 01/2013 - 09/2007
3	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 02/2012 - 03/2011
3	Ankle Fractures 02/2010 - 04/2008
2	Hypertrophy 01/2022 - 06/2010
2	Obesity 01/2022 - 01/2007
2	Morbid Obesity 01/2022 - 01/2007
2	Frailty 01/2021 - 01/2020
2	Fatigue 01/2021 - 10/2020
2	Gout 01/2021 - 05/2014
2	Chronic Disease (Chronic Diseases) 12/2020 - 01/2019
2	Myasthenia Gravis 08/2019 - 06/2011
2	Leukemia 01/2019 - 03/2013
2	Abdominal Aortic Aneurysm 10/2018 - 01/2006
2	Fibrosis (Cirrhosis) 01/2018 - 03/2010
2	Hyperkalemia 10/2016 - 09/2015
2	Ischemia 03/2016 - 12/2008
2	Deglutition Disorders (Dysphagia) 07/2015 - 02/2009
2	Osteoarthritis 07/2015 - 01/2011
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2014 - 01/2014
2	Systemic Vasculitis 12/2014 - 06/2012
2	Autoimmune Diseases (Autoimmune Disease) 12/2014 - 07/2009
2	Proteinuria 05/2013 - 03/2010
2	Leukopenia 02/2013 - 09/2007

Drug/Important Bio-Agent (IBA)

15	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2022 - 07/2010
11	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 09/2007
10	GlucocorticoidsIBA 01/2022 - 07/2010
9	CreatinineIBA 01/2021 - 03/2010
7	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2020 - 09/2007
6	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 01/2007
6	Rituximab (Mabthera)FDA Link 08/2019 - 07/2009
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2002
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2004
4	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 01/2016
4	AutoantibodiesIBA 05/2020 - 07/2009
4	Azathioprine (Imuran)FDA LinkGeneric 06/2015 - 07/2010
3	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 01/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 02/2012
3	Methylprednisolone FDA LinkGeneric 01/2019 - 08/2013
3	AnticoagulantsIBA 12/2018 - 12/2008
3	PotassiumIBA 10/2016 - 07/2012
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2014 - 01/2007
3	MineralsIBA 04/2010 - 04/2005
2	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2021 - 01/2021
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 11/2021 - 01/2021
2	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2021 - 01/2021
2	Sodium-Glucose Transport ProteinsIBA 11/2021 - 01/2021
2	Antidepressive Agents (Antidepressants)IBA 01/2021 - 12/2019
2	Pharmaceutical PreparationsIBA 01/2021 - 09/2015
2	Phosphotransferases (Kinase)IBA 12/2019 - 06/2011
2	CollagenIBA 02/2019 - 09/2012
2	Insulin Glargine (Lantus)FDA Link 01/2019 - 01/2018
2	CurcuminIBA 10/2018 - 01/2018
2	C-Reactive ProteinIBA 10/2018 - 08/2005
2	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2018 - 04/2006
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2018 - 07/2005
2	Lidocaine (Xylocaine)FDA LinkGeneric 07/2015 - 04/2008
2	Clonidine (ST 155)FDA LinkGeneric 12/2014 - 02/2014
2	SteroidsIBA 03/2014 - 01/2014
2	AntibodiesIBA 01/2013 - 03/2011

Therapy/Procedure

26	Therapeutics 01/2022 - 10/2003
14	Renal Dialysis (Hemodialysis) 02/2022 - 04/2005
9	Plasma Exchange 01/2022 - 04/2011
6	Remission Induction 01/2022 - 05/2009
5	Peritoneal Dialysis 01/2022 - 01/2012
4	Length of Stay 01/2020 - 01/2007
4	Arthroplasty 01/2013 - 06/2006
3	Hip Replacement Arthroplasty (Total Hip Replacement) 07/2015 - 01/2007
3	General Anesthesia 04/2015 - 02/2010
3	Blood Transfusion (Blood Transfusions) 12/2013 - 12/2007
2	Renal Replacement Therapy (Therapies, Renal Replacement) 05/2021 - 07/2012
2	Transplantation 01/2020 - 01/2018
2	Stents 11/2019 - 01/2006
2	Drug Therapy (Chemotherapy) 01/2019 - 05/2014
2	Anesthesia 04/2015 - 02/2010